Cases & Deals

Idenix asserts patent infringement against Gilead in UK related to Sovaldi® and Harvoni®

Clients Idenix Pharmaceuticals LLC

Jones Day represents Idenix Pharmaceuticals LLC (a subsidiary of Merck & Co., Inc.) in patent litigation against Gilead in the Patents Court and Court of Appeal in the UK over sofosbuvir, the active ingredient in Sovaldi® and Harvoni®, Gilead's blockbuster drugs for treating Hepatitis C. Subject matter is nucleoside analogs and prodrugs for treating Flaviviridae infections, including HCV.

Idenix Pharmaceuticals v. Gilead Sciences Inc and others; HP14D01069 (Patents Court) and A3/2015/0450 (Court of Appeal)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.